139 related articles for article (PubMed ID: 26205145)
1. Insights into the clinical value of cyclin-dependent kinase 5 in glioma: a retrospective study.
Yushan R; Wenjie C; Suning H; Yiwu D; Tengfei Z; Madushi WM; Feifei L; Changwen Z; Xin W; Roodrajeetsing G; Zuyun L; Gang C
World J Surg Oncol; 2015 Jul; 13():223. PubMed ID: 26205145
[TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between miR-218 and CDK6 expression and their biological impact on glioma cell proliferation and apoptosis].
Zhang JM; Sun CY; Yu SZ; Wang Q; An TL; Li YY; Kong YL; Wen YJ
Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):454-9. PubMed ID: 22088371
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclinD1 and Ki-67 proteins in gliomas and its clinical significance.
Qu DW; Xu HS; Han XJ; Wang YL; Ouyang CJ
Eur Rev Med Pharmacol Sci; 2014; 18(4):516-9. PubMed ID: 24610618
[TBL] [Abstract][Full Text] [Related]
5. Slit2 and Robo1 expression as biomarkers for assessing prognosis in brain glioma patients.
Liu L; Li W; Geng S; Fang Y; Sun Z; Hu H; Liang Z; Yan Z
Surg Oncol; 2016 Dec; 25(4):405-410. PubMed ID: 27916173
[TBL] [Abstract][Full Text] [Related]
6. Deregulated expression of cry1 and cry2 in human gliomas.
Luo Y; Wang F; Chen LA; Chen XW; Chen ZJ; Liu PF; li FF; Li CY; Liang W
Asian Pac J Cancer Prev; 2012; 13(11):5725-8. PubMed ID: 23317246
[TBL] [Abstract][Full Text] [Related]
7. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
[TBL] [Abstract][Full Text] [Related]
8. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake.
Tanaka K; Yamamoto Y; Maeda Y; Yamamoto H; Kudomi N; Kawai N; Toyohara J; Nishiyama Y
Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of the WEE1 kinase in gliomas.
Music D; Dahlrot RH; Hermansen SK; Hjelmborg J; de Stricker K; Hansen S; Kristensen BW
J Neurooncol; 2016 Apr; 127(2):381-9. PubMed ID: 26738845
[TBL] [Abstract][Full Text] [Related]
10. Association between Ki-67 Labeling index and Histopathological Grading of Glioma in Indonesian Population.
Theresia E; Malueka RG; Pranacipta S; Kameswari B; Dananjoyo K; Asmedi A; Wicaksono AS; Hartanto RA; Dwianingsih EK
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1063-1068. PubMed ID: 32334471
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas.
Tsai WC; Hueng DY; Lin CR; Yang TC; Gao HW
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187376
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.
Xue H; Guo X; Han X; Yan S; Zhang J; Xu S; Li T; Guo X; Zhang P; Gao X; Liu Q; Li G
Oncotarget; 2016 Jan; 7(4):4785-805. PubMed ID: 26715733
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Roundabout4 predicts poor prognosis of primary glioma patients via correlating with microvessel density.
Cai H; Xue Y; Liu W; Li Z; Hu Y; Li Z; Shang X; Liu Y
J Neurooncol; 2015 May; 123(1):161-9. PubMed ID: 25859844
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
He J; Deng Y; Yang G; Xie W
J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
[TBL] [Abstract][Full Text] [Related]
15. Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomas.
Zeng J; Zhang XK; Chen HD; Zhong ZH; Wu QL; Lin SX
Oncotarget; 2016 Feb; 7(8):8944-55. PubMed ID: 26771840
[TBL] [Abstract][Full Text] [Related]
16. The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients.
Yang X; Li D; Cheng S; Fan K; Sheng L; Zhang J; Feng B; Xu Z
Tumour Biol; 2014 Nov; 35(11):11091-5. PubMed ID: 25099618
[TBL] [Abstract][Full Text] [Related]
17. Gab2 expression in glioma and its implications for tumor invasion.
Shi L; Sun X; Zhang J; Zhao C; Li H; Liu Z; Fang C; Wang X; Zhao C; Zhang X; Zhou F; Lu S; Luo R; Zhang B
Acta Oncol; 2013 Nov; 52(8):1739-50. PubMed ID: 23231021
[TBL] [Abstract][Full Text] [Related]
18. The expression of SALL4 in patients with gliomas: high level of SALL4 expression is correlated with poor outcome.
Zhang L; Yan Y; Jiang Y; Cui Y; Zou Y; Qian J; Luo C; Lu Y; Wu X
J Neurooncol; 2015 Jan; 121(2):261-8. PubMed ID: 25359397
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas.
Wang L; Qin H; Li L; Zhang Y; Tu Y; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
Med Oncol; 2012 Dec; 29(5):3491-7. PubMed ID: 22926920
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas.
Wu X; Wu F; Xu D; Zhang T
J Neurooncol; 2016 Apr; 127(2):221-32. PubMed ID: 26757925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
